Antimicrob Agents Chemother
- JOGIRAJU V, Weber E, Hindman J, West S, et al
Pharmacokinetics of long-acting lenacapavir in participants with hepatic or renal
impairment.
Antimicrob Agents Chemother. 2024 Mar 8:e0134423. doi: 10.1128/aac.01344.
Arch Dis Child
- SOUSA NUNES B, Marques-Matos C, Conceicao C, Silva TM, et al
Progressive multifocal leukoencephalopathy in children with HIV: still a
challenge.
Arch Dis Child. 2024 Mar 4:archdischild-2023-326609.
BMJ
- MAHASE E
HIV: WHO reports "worrying" increase in resistance to key antiretroviral
treatment.
BMJ. 2024;384:q573.
Cell
- WANG Q, Clark KM, Tiwari R, Raju N, et al
The CARD8 inflammasome dictates HIV/SIV pathogenesis and disease progression.
Cell. 2024;187:1223-1237.
HIV Med
- NOE S, Ivanova A, Johnsson-Oldenbuttel C, Schafer G, et al
Immunological alterations with GLP-1 agonists in people living with HIV.
HIV Med. 2024 Mar 3. doi: 10.1111/hiv.13631.
- FURSA O, Bannister W, Neesgaard B, Podlekareva D, et al
SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people
with HIV across Europe in the multinational EuroSIDA cohort.
HIV Med. 2024 Mar 3. doi: 10.1111/hiv.13620.
- PALICH R, Rodger AJ, Nicholls EJ, Wright T, et al
Experiences with health care services and HIV testing after sexual assault in
cisgender gay, bisexual and other men who have sex with men and transgender
people.
HIV Med. 2024 Mar 3. doi: 10.1111/hiv.13629.
- TAHA AM, Elrosasy A, Mahmoud AM, Saed SAA, et al
The effect of HIV and mpox co-infection on clinical outcomes: Systematic review
and meta-analysis.
HIV Med. 2024 Mar 5. doi: 10.1111/hiv.13622.
J Am Acad Dermatol
- SOOD S, Geng R, Heung M, Yeung J, et al
Use of Biologic Treatment in Psoriasis Patients with HIV: A Systematic Review.
J Am Acad Dermatol. 2024 Mar 5:S0190-9622(24)00442.
J Infect Dis
- COLON W, Oriol Mathieu V, Hural J, Hattingh L, et al
HIV Diagnostics and Vaccines: It Takes Two to Tango.
J Infect Dis. 2024 Mar 7:jiae113. doi: 10.1093.
- WILCOX CS, Herbert C, Wang C, Ma Y, et al
Signals From Inflamed Perivascular Adipose Tissue Contribute to Small Vessel
Dysfunction in Women Living With the Human Immunodeficiency Virus.
J Infect Dis. 2024 Mar 1:jiae094. doi: 10.1093.
J Med Virol
- XIE M, Wang Z, Zhao F, Li Y, et al
Structure-based design of diarylpyrimidines and triarylpyrimidines as potent
HIV-1 NNRTIs with improved metabolic stability and drug resistance profiles.
J Med Virol. 2024;96:e29502.
JAMA
- PECK RN, Issarow B, Kisigo GA, Kabakama S, et al
Linkage Case Management and Posthospitalization Outcomes in People With HIV: The
Daraja Randomized Clinical Trial.
JAMA. 2024 Mar 6:e242177. doi: 10.1001/jama.2024.2177.
- AMICO KR
A Linkage-to-Care Intervention for Hospitalized People With HIV: High Value at
Minimal Cost.
JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.0271.
- HARRIS E
Long-Acting HIV Treatment Superior to Daily Oral Drugs.
JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1570.
Nat Med
- NARASIMHAN M, Hargreaves JR, Logie CH, Abdool-Karim Q, et al
Self-care interventions for women's health and well-being.
Nat Med. 2024 Mar 7. doi: 10.1038/s41591-024-02844.
Pediatr Infect Dis J
- NYAKATO P, Boulle A, Wood R, Eley B, et al
Self-transfers, Hospital Admissions and Mortality Among Children and Adolescents
Lost to Follow-up From Antiretroviral Therapy Programs in the Western Cape, South
Africa Between 2004 and 2019: Linkage to Provincial Records.
Pediatr Infect Dis J. 2024 Feb 21. doi: 10.1097/INF.0000000000004281.
PLoS One
- MUTAMBA BB, Rukundo GZ, Sembajjwe W, Nakasujja N, et al
A 'hidden problem': Nature, prevalence and factors associated with sexual
dysfunction in persons living with HIV/AIDS in Uganda.
PLoS One. 2024;19:e0295224.
- OGELLO VA, Rono BK, Ngure K, Sedah E, et al
Acceptability and feasibility of long-term, real-time electronic adherence
monitoring of HIV pre-exposure prophylaxis (PrEP) use among young women in Kenya:
A mixed methods study.
PLoS One. 2024;19:e0299168.
- SACKEYA E, Beru MM, Angmortey RN, Opoku DA, et al
Survival trends among people living with human immunodeficiency virus on
antiretroviral treatment in two rural districts in Ghana.
PLoS One. 2024;19:e0290810.
- BESCHORNER N, Kunzle P, Voges M, Hauber I, et al
Preclinical toxicity analyses of lentiviral vectors expressing the HIV-1
LTR-specific designer-recombinase Brec1.
PLoS One. 2024;19:e0298542.
- ROUCOUX G, Thonon F, Zucman D, Rey D, et al
Questioning the "Ease" in disease: Was living with HIV a burden or boost during
the first wave of Covid-19 in France? A qualitative study (COVIDHIV).
PLoS One. 2024;19:e0295223.
PLoS Pathog
- BENNETT SJ, Yalcin D, Privatt SR, Ngalamika O, et al
Antibody profiling and predictive modeling discriminate between Kaposi sarcoma
and asymptomatic KSHV infection.
PLoS Pathog. 2024;20:e1012023.
Proc Natl Acad Sci U S A
- OBRIEN SJ
Legacy of a magic gene-CCR5-?32: From discovery to clinical benefit in a
generation.
Proc Natl Acad Sci U S A. 2024;121:e2321907121.
Science
- COHEN J
Skin side effects stymie advance of HIV vaccine.
Science. 2024;383:1044.
Vaccine
- BEAVIS AC, Dienger-Stambaugh K, Briggs K, Chen Z, et al
A J Paramyxovirus-vectored HIV vaccine induces humoral and cellular responses in
mice.
Vaccine. 2024 Mar 4:S0264-410X(24)00227-5. doi: 10.1016/j.vaccine.2024.
- MENG L, Harris L, Shaw L, Lymon H, et al
Social and demographic factors associated with receipt of a COVID-19 vaccine
initial booster dose and with interval between primary series completion and
initial booster dose uptake among persons aged >/= 12 years, United States, August
2021-October 2
Vaccine. 2024 Mar 6:S0264-410X(24)00271-8. doi: 10.1016/j.vaccine.2024.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016